{
  "N/R/U": null,
  "Applicant": "Ferring Pharmaceuticals A/S",
  "BLA Number": "125700",
  "Proprietary Name": "Adstiladrin",
  "Proper Name": "nadofaragene firadenovec-vncg",
  "BLA Type": "351(a)",
  "Strength": "3x10^11 viral particles (vp)/mL",
  "Dosage Form": "For Suspension",
  "Route of Administration": "Intravesical",
  "Product Presentation": "Single-Dose Vial",
  "Marketing Status": "Rx",
  "Licensure": "Licensed",
  "Approval Date": "16-Dec-22",
  "Ref. Product Proper Name": null,
  "Ref. Product Proprietary Name": null,
  "Supplement Number": "0",
  "Submission Type": "Original",
  "License Number": "2222",
  "Product Number": "1",
  "Center": "CBER",
  "Date of First Licensure": "16-Dec-22",
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": "16-Dec-34",
  "Orphan Exclusivity Exp. Date": null
}